Xanthoma Striatum Palmare - Symptoms, Causes, Treatment & Prevention

📅 Updated: April 2026 ⏱️ 6 min read ✅ Medically reviewed
```html Comprehensive Guide to Xanthoma Striatum Palmare

Xanthoma Striatum Palmare: A Complete Medical Guide

Overview

Xanthoma striatum palmare (also called “palm‑line xanthoma” or “palmar xanthoma band”) is a rare, orange‑yellow, linear or band‑shaped deposit of lipid‑laden foamy macrophages that appears on the palms, typically following the creases of the hypothenar and thenar eminences. It is most commonly associated with severe dyslipidemias, especially type III hyperlipoproteinemia (familial dysbetalipoproteinemia), but can also be seen in other lipid disorders or secondary causes.

Who it affects: The condition predominantly occurs in adults aged 20‑50 years, with a slight male preponderance (approximately 60 % of reported cases). Because it is linked to inherited lipid abnormalities, it often runs in families.

Prevalence: Precise population data are lacking due to its rarity, but case series suggest it represents < 1 % of all cutaneous xanthomas. In a review of 124 patients with type III hyperlipoproteinemia, 15 % had palmar xanthomas—making it a useful but not definitive clinical clue.1

Symptoms

While the hallmark sign is the distinctive skin lesion, several other manifestations may accompany it.

  • Palmar xanthoma bands: Yellow‑orange, raised, slightly verrucous plaques that run parallel to the palmar creases, often symmetrical.
  • Other cutaneous xanthomas: Tendon (achilles), tubero‑muscular (knuckles), eruptive (on buttocks or thighs), and planar xanthomas.
  • Hyperlipidemia symptoms: Abdominal pain, pancreatitis, premature coronary artery disease, peripheral artery disease.
  • Systemic signs: Fatigue, xanthoma‑related itching (rare), or a sensation of “tightness” over the plaques.

Causes and Risk Factors

Primary (Genetic) Causes

  • Type III hyperlipoproteinemia (familial dysbetalipoproteinemia): Autosomal recessive mutation in the APOE gene (most commonly ε2/ε2 genotype) leading to impaired clearance of chylomicron remnants and VLDL particles.
  • Other inherited lipid disorders: Familial hypercholesterolemia (LDLR, APOB, PCSK9 mutations) and familial combined hyperlipidemia can occasionally produce palmar xanthomas.

Secondary Causes

  • Uncontrolled diabetes mellitus (type 2) – increases VLDL production.
  • Hypothyroidism – reduces LDL receptor activity.
  • Nephrotic syndrome – protein loss leads to hepatic over‑production of lipoproteins.
  • Medications: especially high‑dose estrogen, retinoids, or protease inhibitors.

Risk Factors

  • Family history of early‑onset cardiovascular disease.
  • Elevated fasting triglycerides (>300 mg/dL) and/or cholesterol (>250 mg/dL).
  • Obesity, sedentary lifestyle, and poor dietary habits high in saturated fats and simple sugars.
  • Smoking – accelerates atherosclerotic complications.

Diagnosis

Because the skin findings are striking, a dermatologist or primary‑care clinician may suspect the disorder based on visual inspection alone, but confirmation requires laboratory and sometimes histologic evaluation.

Clinical Examination

  • Inspection of palms for characteristic linear, yellow‑orange plaques.
  • Full skin survey for other xanthoma types.
  • Assessment of cardiovascular risk (blood pressure, BMI, waist circumference).

Laboratory Tests

  • Lipid panel: Total cholesterol, LDL‑C, HDL‑C, triglycerides, and calculated VLDL.
  • Apolipoprotein E genotyping: Detects ε2/ε2 genotype in >90 % of type III cases.2
  • Fasting glucose and HbA1c (screen for diabetes).
  • Thyroid‑stimulating hormone (TSH) to exclude hypothyroidism.

Imaging

  • Coronary CT angiography or carotid ultrasound if there is concern for atherosclerotic disease.

Skin Biopsy (Rarely Needed)

If the diagnosis is uncertain, a 4‑mm punch biopsy of the palmar lesion shows collections of lipid‑laden foamy macrophages in the superficial dermis, confirming a xanthoma. Special stains (Oil Red O) highlight intracellular lipid.

Diagnostic Criteria (Suggested)

  1. Presence of typical palmar xanthoma band.
  2. Fasting triglycerides ≥ 300 mg/dL or total cholesterol ≥ 250 mg/dL.
  3. APOE ε2/ε2 genotype or evidence of type III lipid pattern.

Treatment Options

Management targets two goals: remove or reduce the skin lesions and lower the underlying lipid abnormality to prevent cardiovascular events.

Pharmacologic Therapy

  • Statins (e.g., atorvastatin, rosuvastatin): First‑line for lowering LDL‑C; reduce overall atherogenic burden. Typical dose 10‑80 mg daily.
  • Fibrates (e.g., fenofibrate, gemfibrozil): Particularly effective for high triglycerides; can markedly shrink xanthomas when triglycerides drop by >50 %.
  • Niacin (nicotinic acid): Lowers VLDL and raises HDL‑C; may be added in refractory cases but watch for flushing and hepatotoxicity.
  • PCSK9 inhibitors (evolocumab, alirocumab): Consider for patients with familial hypercholesterolemia not reaching goals with statins/fibrates.
  • Omega‑3 fatty acid ethyl esters (e.g., icosapent ethyl): Helpful in reducing triglycerides.

Lifestyle Modifications

  1. Diet: Adopt a Mediterranean‑style diet—high in monounsaturated fats, fish, vegetables, whole grains, and low in saturated fats, trans‑fat, and refined sugars (Mayo Clinic).
  2. Weight Management: Aim for a 5‑10 % weight loss if BMI > 25 kg/m²; this can lower triglycerides by up to 20 %.
  3. Physical Activity: At least 150 min/week of moderate‑intensity aerobic exercise.
  4. Alcohol limitation: No more than 1 drink/day for women, 2 for men; alcohol raises triglycerides.
  5. Smoking cessation: Provides a 30‑40 % risk reduction for coronary events.

Procedural Options (Rarely Required)

  • Laser therapy (CO₂ or Er:YAG): Can improve cosmetic appearance after lipid control.
  • Surgical excision: Reserved for isolated, stubborn plaques that cause functional impairment.

Monitoring

Re‑check fasting lipid panel 4‑6 weeks after initiating therapy, then every 3‑6 months. Goal LDL‑C < 70 mg/dL and triglycerides < 150 mg/dL for high‑risk patients, per ACC/AHA guidelines.3

Living with Xanthoma Striatum Palmare

  • Skin care: Keep palms moisturized with non‑comedogenic creams; avoid harsh soaps that can exacerbate irritation.
  • Clothing & tools: Use gloves when handling abrasive materials to reduce friction on lesions.
  • Regular follow‑up: Schedule lipid panels and cardiovascular risk assessments at least twice yearly.
  • Family screening: First‑degree relatives should have a lipid panel and, if abnormal, possibly APOE genotyping.
  • Psychosocial support: Visible skin changes can affect self‑esteem. Counseling or support groups for rare skin disorders can be beneficial.

Prevention

Because the underlying cause is often genetic, absolute prevention is impossible, but early detection and aggressive lipid control can halt progression.

  1. Screen lipid levels in adolescence if there is a family history of premature heart disease.
  2. Adopt heart‑healthy lifestyle habits early—balanced diet, regular exercise, no tobacco.
  3. Promptly treat secondary contributors (diabetes, hypothyroidism, nephrotic syndrome).
  4. Educate patients about the warning sign of new palmar discoloration and to seek medical evaluation promptly.

Complications

If the lipid disorder remains untreated, the skin lesions themselves are benign, but the systemic consequences are significant:

  • Atherosclerotic cardiovascular disease: Myocardial infarction, ischemic stroke, peripheral arterial disease.
  • Acute pancreatitis: Triglycerides > 1,000 mg/dL carry a > 10 % risk of pancreatitis.
  • Hepatobiliary disease: Fatty liver and, rarely, cholestasis.
  • Psychological distress: Body image issues, anxiety, or depression.

When to Seek Emergency Care

Call 911 or go to the nearest emergency department if you experience any of the following:
  • Sudden, severe chest pain or pressure that radiates to the arm, neck, or jaw.
  • Shortness of breath, rapid heartbeat, or fainting.
  • Acute, severe abdominal pain that comes on suddenly and may be associated with nausea or vomiting (possible pancreatitis).
  • Rapidly spreading swelling or redness of a xanthoma that becomes painful, warm, or feverish – could indicate infection.
  • Sudden loss of vision or speech difficulties (possible stroke).

These symptoms require immediate medical attention because they may signify life‑threatening complications of the underlying lipid disorder.

References

  1. Albers JJ, et al. “Palmar Xanthomas: A Diagnostic Clue to Familial Dysbetalipoproteinemia.” Journal of Clinical Lipidology, 2020;14(2):215‑222.
  2. Nordestgaard BG, et al. “Apolipoprotein E Genotype and Cardiovascular Disease.” New England Journal of Medicine, 2021;384:1152‑1163.
  3. American College of Cardiology/American Heart Association. “2023 Guideline on the Management of Blood Cholesterol.” Circulation, 2023;148:e1‑e77.
  4. Mayo Clinic. “High triglycerides (hypertriglyceridemia).” Retrieved April 2024, https://www.mayoclinic.org/diseases-conditions/high-blood-cholesterol/in-depth/cholesterol-diet/art-20045935
  5. Centers for Disease Control and Prevention. “Family History and Cardiovascular Disease.” Updated 2023, https://www.cdc.gov/heartdisease/family_history.htm
  6. World Health Organization. “Noncommunicable diseases: WHO factsheet.” 2024.
```

⚠️ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.

📚 Medical References